{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:28Z","timestamp":1790511028397,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.cmi.2018.02.031","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T13:17:35Z","timestamp":1521379055000},"page":"678-679","source":"Crossref","is-referenced-by-count":23,"title":["Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?"],"prefix":"10.1016","volume":"24","author":[{"given":"M.","family":"Mikulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.02.031_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004386.pub2","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter-Gvili","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2018.02.031_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.02.031_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.02.031_bib4","first-page":"13","article-title":"Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials","volume":"69","author":"Kimura","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.02.031_bib5","series-title":"Antimicrobial resistance surveillance in Europe 2016. Annual report of the European antimicrobial resistance surveillance network (ears-net)","author":"Control ECfDPa","year":"2017"},{"key":"10.1016\/j.cmi.2018.02.031_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10096-004-1264-8","article-title":"Prevalence and risk factors of extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae in an israeli long-term care facility","volume":"24","author":"Mendelson","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.02.031_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-13-356","article-title":"Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance","volume":"13","author":"Garnica","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.02.031_bib8","first-page":"20","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.02.031_bib9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the european bone marrow transplantation group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.02.031_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cmi.2017.11.019","article-title":"Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single centre before-after study","volume":"24","author":"Yeshurun","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.02.031_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.bbmt.2015.06.017","article-title":"Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation","volume":"21","author":"Satlin","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.02.031_bib12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.02.031_bib13","first-page":"299","article-title":"Incidence and clinical impact of extended-spectrum-beta-lactamase (esbl) production and fluoroquinolone resistance in bloodstream infections caused by escherichia coli in patients with hematological malignancies","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.02.031_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2017.08.024","article-title":"Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of t cell-replete transplantation from a haploidentical donor","volume":"24","author":"Mikulska","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.02.031_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","article-title":"Use of antibacterial prophylaxis for patients with neutropenia. Australian consensus guidelines 2011 steering committee","volume":"41","author":"Slavin","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.cmi.2018.02.031_bib16","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18302088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18302088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T22:07:07Z","timestamp":1570918027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18302088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1198743X18302088"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.02.031","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}